Dear Site Directors and Affiliate Members,
There has been a recent increase in reports of dengue from travelers to Guadeloupe and Martinique including 5 patients seen in Montreal (MTL) by Michael Libman and colleagues. Three of these patients have confirmed dengue (2 have tests pending) and none have shown signs of severe disease. In the last 3 months, there have been an additional 2 patients with uncomplicated dengue reported by GeoSentinel sites from these two islands. There have also been reports from several islands, especially Cuba but also the Dominican Republic and many countries in South and Central America.
Following is a summary from Sante Publique (in French) which notes a resurgence of confirmed dengue cases in Guadeloupe and Martinique (but not Saint-Martin or Saint-Barthelemy):
https://www.santepubliquefrance.fr/content/download/514951/document_file/pe_dengue_antilles_20230302.pdf?version=1
And the ECDC: https://www.ecdc.europa.eu/en/dengue-monthly “In the French Antilles from 1 January and up to 15 December 2022, confirmed cases of dengue were reported from Guadeloupe (35), Martinique (10), and Saint-Martin (1). In Guadeloupe, the number of suspected and confirmed cases has increased sharply since October 2022, with a total of 850 suspected cases and 35 confirmed cases up to 15 December 2022. This is an increase of 170 suspected cases and 12 confirmed cases since 30 November 2022.)”
We have already disseminated information on the dengue outbreak in Cuba (although this has continued to lead to more infected travelers since our publication): Dengue outbreak among travellers returning from Cuba-GeoSentinel surveillance network, January-September 2022. J Travel Med. 2022 Dec 27:taac139. doi: 10.1093/jtm/taac139. Epub ahead of print. PMID: 36573483.
Please be aware of the apparent increased risk of dengue in Guadeloupe and Martinique and the need to counsel travelers to these destinations on personal protection measures and to consider this diagnosis in travelers returning from these destinations.
Best wishes,
David
Davidson H. Hamer, MD
Surveillance lead, GeoSentinel
Professor of Global Health and Medicine
Boston University Schools of Public Health and Medicine
EVENTS
FAQ
DOCUMENT LIBRARY (FOR MEMBERS)
Dear Site Directors and Affiliate Members,
There has been a recent increase in reports of dengue from travelers to Guadeloupe and Martinique including 5 patients seen in Montreal (MTL) by Michael Libman and colleagues. Three of these patients have confirmed dengue (2 have tests pending) and none have shown signs of severe disease. In the last 3 months, there have been an additional 2 patients with uncomplicated dengue reported by GeoSentinel sites from these two islands. There have also been reports from several islands, especially Cuba but also the Dominican Republic and many countries in South and Central America.
Following is a summary from Sante Publique (in French) which notes a resurgence of confirmed dengue cases in Guadeloupe and Martinique (but not Saint-Martin or Saint-Barthelemy):
https://www.santepubliquefrance.fr/content/download/514951/document_file/pe_dengue_antilles_20230302.pdf?version=1
And the ECDC: https://www.ecdc.europa.eu/en/dengue-monthly “In the French Antilles from 1 January and up to 15 December 2022, confirmed cases of dengue were reported from Guadeloupe (35), Martinique (10), and Saint-Martin (1). In Guadeloupe, the number of suspected and confirmed cases has increased sharply since October 2022, with a total of 850 suspected cases and 35 confirmed cases up to 15 December 2022. This is an increase of 170 suspected cases and 12 confirmed cases since 30 November 2022.)”
We have already disseminated information on the dengue outbreak in Cuba (although this has continued to lead to more infected travelers since our publication): Dengue outbreak among travellers returning from Cuba-GeoSentinel surveillance network, January-September 2022. J Travel Med. 2022 Dec 27:taac139. doi: 10.1093/jtm/taac139. Epub ahead of print. PMID: 36573483.
Please be aware of the apparent increased risk of dengue in Guadeloupe and Martinique and the need to counsel travelers to these destinations on personal protection measures and to consider this diagnosis in travelers returning from these destinations.
Best wishes,
David
Davidson H. Hamer, MD
Surveillance lead, GeoSentinel
Professor of Global Health and Medicine
Boston University Schools of Public Health and Medicine